GLYCOMIMETICS INC (GLYC)
GlycoMimetics, Inc. engages in the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. It develops proprietary glycomimetics that inhibit disease related functions of carbohydrates. The company was founded by Rachel K. King and John L. Magnani on April 4, 2003 and is headquartered in Rockville, MD.
Address
9708 MEDICAL CENTER DRIVE
ROCKVILLE, MD 20850
Founded
2003
Number of Employees
35
Website
http://www.glycomimetics.com
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)